Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
66 hedge funds and large institutions have $180M invested in Syneron Medical Ltd in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 17 closing their positions.
661% more call options, than puts
Call options by funds: $236K | Put options by funds: $31K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
16% less funds holding
Funds holding: 79 → 66 (-13)
35% less capital invested
Capital invested by funds: $276M → $180M (-$95.9M)
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGHMC
Dalton, Greiner, Hartman, Maher & Co
New York
|
+$3.16M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$2.31M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.93M |
| 4 |
SM
Senvest Management
New York
|
+$1.89M |
| 5 |
RA
Royce & Associates
New York
|
+$1.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$10.6M |
| 2 |
HM
HealthCor Management
New York
|
-$2.8M |
| 3 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$2.02M |
| 4 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$1.54M |
| 5 |
JP Morgan Chase
New York
|
-$1.06M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EEG
76
E.E. Geduld
| – | -$106K | -10,000 | Closed |
|
|
PAM
77
Panagora Asset Management
Boston,
Massachusetts
| – | -$34K | -3,236 | Closed |
|
|
TDC
78
Thompson Davis & Co
Richmond,
Virginia
| – | -$3K | -250 | Closed |
|
|
UMA
79
USA Mutuals Advisors
Dallas,
Texas
| – | -$2K | -166 | Closed |
|
80
Citigroup
New York
| – | -$1K | -98 | Closed |
|
81
Simplex Trading
Chicago,
Illinois
| – | -$653 | -68 | Closed |
|
ELOS Hedge Fund Activity: Q3 2015 in Review
66 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2015, worth a combined $180M — down 35% from $276M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of ELOS and 4 opened new positions — a net loss of 13 holders — while 24 trimmed existing stakes and 23 added.
The largest buyer was Dalton, Greiner, Hartman, Maher & Co, adding an estimated $3.16M. The largest seller was Visium Asset Management, exiting entirely with an estimated $10.6M sold.
- 66 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2015, down from 79 in Q2 2015.
- Funds reported $180M of Syneron Medical Ltd stock for Q3 2015, down 35% quarter-over-quarter.
- 4 funds opened new Syneron Medical Ltd positions in Q3 2015 and 17 closed out, a net change of -13 holders.
- The largest Syneron Medical Ltd buyer in Q3 2015 was Dalton, Greiner, Hartman, Maher & Co, an estimated $3.16M added.
- The largest Syneron Medical Ltd seller in Q3 2015 was Visium Asset Management, an estimated $10.6M sold.
Based on aggregated 13F filings for Q3 2015.